Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(E)-Alprenoxime is the isomer of the Alprenoxime which is a site-activated ocular β-blocker.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | (E)-Alprenoxime is the isomer of the Alprenoxime which is a site-activated ocular β-blocker. |
In vivo | Interspecies scaling considerations predict that the doses selected of Alprenoxime (1 and 5 mg/kg) are pharmacologically comparable or greater than doses used in rodent studies (2 and 6 mg/kg). More importantly, the prolonged ocular antihypertensive effects that are shown with 1% ophthalmic solutions indicate that the i.v. dose tested in the present study is likely to be more than two orders of magnitude greater than probable therapeutic doses. |
別名 | CDDD-1815 |
分子量 | 262.35 |
分子式 | C15H22N2O2 |
CAS No. | 125720-84-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(E)-Alprenoxime 125720-84-5 Others CDDD 1815 Alprenoxime (E) Alprenoxime CDDD1815 CDDD-1815 (E)Alprenoxime Inhibitor inhibitor inhibit